Cancer BiologyJournal of Biological ChemistryPeer-reviewed
ErbB2/HER2 governs CDK4 inhibitor sensitivity and timing and irreversibility of G1/S transition by altering c-Myc and cyclin D function
Ayaka Ichikawa Nagasato, Ken Murakami, Kazuhiro Aoki, Mariko Okada
This study shows how ErbB2 levels affect CDK4 inhibitor sensitivity and the timing of G1/S transition by altering c-Myc and cyclin D function in breast cancer cells.
2 citations